The University of Cincinnati Sponsored Research Services Division was awarded an $817,296 project grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will support research on spreading depolarizations as a predictive biomarker of post-traumatic epilepsy from June 1, 2023 through May 31, 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research...
Children's Hospital Medical Center received a $1.51 million project grant award from the Department of the Army Medical Command. The grant was awarded on July 15, 2022 under the Military Medical Research and Development program (CFDA 12.420) to support the establishment of network connectivity and microvascular imaging biomarkers for tuberous sclerosis complex. Through this three-year project concluding on July 14, 2025, the awardee will work to transform healthcare for service members and the...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,342,184.00 to the University of Cincinnati to conduct research on "STATHMIN POST-TRANSLATIONAL PROCESSING AS A MECHANISM OF CASTRATION RESISTANCE." The project aims to investigate this biological mechanism with the potential to yield new treatments for military-relevant medical conditions. The award has a performance...
The Department of the Army Medical Command awarded a $413,400 Project Grant to Children's Home Healthcare of Cincinnati, OH through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2023 exploring the role of endoplasmic reticulum stress and systemic inflammation in blunt traumatic brain injury-induced optic nerve damage. The Military Medical Research and Development program supports basic, applied, and...
This $1,561,794 Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research led by the University of Cincinnati to investigate the role of plasmacytoid dendritic cells (pDCs) in immune suppression and treatment resistance in acute myeloid leukemia. The award will fund a 3-year research project from September 2024 through August 2027 to advance the scientific understanding of how pDCs...
The Institute For Cancer Research at Temple University received a $187,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year award, which runs from April 1, 2021 through March 31, 2023, will support research into therapeutic targeting of P300/CBP in clear cell renal cell carcinoma. The Military Medical Research and Development program aims to transform military and public...
The Department of the Army Medical Command awarded Duke University a $472,184 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2024 to exploit ferropotosis for the treatment of RB1-deficient lethal prostate cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care...
This federal Project Grant award of $110,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by University College Dublin (UCD) to investigate the role of the unfolded protein response in clear cell renal cell carcinoma, with the goal of developing novel therapeutic strategies for this disease. The project will be conducted over a one-year period from September 1, 2024 to August 31, 2025. The Military Medical...
The Department of the Army Medical Command awarded a $157,500 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 1, 2021 to May 31, 2022 to restore functional ARF tumor suppression in non-small cell lung carcinoma through the use of peptide mimics. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming...
The University of Cincinnati was awarded a $1.16 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The three-year grant will fund research to target proliferating cell nuclear antigen for enhancing the efficacy of radiotherapy in prostate cancer. Through September 2025, the University will investigate medical solutions to improve radiation treatment outcomes for prostate cancer patients, in line with the Military...